Search results

Showing 238 results

Patients Involved – HIV patients actively involved in multiple phases

Patient Engagement

Introduction A case report on patients recruited by Janssen R&D in a program constructed for the EATG members. Afterwards, the course was handed over for further capacity building within...

Introduction to Patient Involvement in Digital Health

Patient Engagement

Traditionally, health data has been generated by documenting patients’ records (i.e. clinicians’ notes, lab results, prescriptions etc.) in a paper-based system. However, this system has several challenges such as...

Interview with Souzi Makri

Patient Engagement

Transcription My name is Souzi Makri, I come from Cyprus. I’m an expert patient, I’m involved with the Cyprus League Against Rheumatism. I’m a member of the board,...

Patients Involved – DevelopAKUre for AKU

Patient Engagement

Introduction An example of public-private partnership from diverse international groups in industry (Sobi), patient organisations (AKU Society and ALCAP), hospitals (Royal Liverpool, Hospital Necker, and National Institute of Rheumatic...

The power of the patient voice in research

Medicines R&D

The power of the patient voice is phenomenal, and inspires, motivates, informs, challenges and advises us during our awareness seminars. It may sound simple – share your experience and...

Patients Involved – HIV DUET Phase III trials

Patient Engagement

Introduction A patients involved case report of patient advocacy in HIV DUET Phase III trials for a novel treatment regime using a combination of two investigational compounds: TMC125 (etravirine)...

Paediatric medicine: Special considerations

Medicines R&D

Special considerations must be taken into account in the development of paediatric medicine, including in terms of research and trial design and ethical concerns.

Compassionate use

Medicines R&D

What is compassionate use? The term ‘compassionate use’ refers to special programmes set up to make unauthorised medicines available to patients. In particular, this may be a way of...

Types of Study in Early Clinical Development

Medicines R&D

Early clinical trials (Phase I and II) must establish above all that an investigational medicinal product is safe for humans, as well as to show that the medicine is...

Developing medicines for children: Overview

Medicines R&D

Developing medicines for children is important, but requires special measures to be taken during clinical development in order to shield children from undue risk.

...5 678 9...20...

Filters

Sort by
- Medicines R&D
- Patient Engagement
Search the Toolbox

Resources on medicines research and development, including patient involvement in the medicines lifecycle

Tools and resources to enable meaningful patient engagement around and within medicines R&D

Find Out More

Toolbox

Guidance

Glossary

Creative Commons

Webinars